INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 30
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Andrew Meds

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'A simpler path to weight loss care'; no insurance, no waiting rooms, free shipping, cancel anytime, 'real provider not an algorithm'; candid about compounded not FDA-approved.

Audienceread

READ: cash-pay adults frustrated with insurance/appointment friction; plain, trust-forward tone.

Pricing & termsnot_found

No prices on first-party pages fetched. (Third-party reviews cite $199 sema / $299 tirz; not verified first-party.)

Clinical relationshipspartial

Unnamed 'Medical Groups' (terms); consent says Andrew Meds has a financial relationship with the entity employing the provider. Third-party site names 'Dr Tel X' - unverified.

Pharmacy & fulfillmentpartial

Unnamed 'pharmacy partners'/'licensed pharmacy'; patient may request transfer.

Advertising snapshotsnapshot

Meta US active exact-phrase keyword: 0 results. Google US last-30-days domain search: 0 ads.

Founding yearpartial

Third-party Texas record: Andrew Meds LLC incorporated 04/29/2026 (very new). Not first-party.

Foundersnot_found

Not named.

    Location & entity contextverified

    2700 Wilcrest Dr., Suite 300, Houston, TX 77042 (in terms/consent).

    Search visibility samplesnapshot

    Free domain-restricted search returned 1 result(s) in a bounded sample, not an indexed-page count; top pages listed in sources. No rank/traffic data (paid analytics excluded).

    THE MODERN DOSING WEEKLY

    The peptide news
    that changes your week.

    Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.